PharmaCyte Biotech, Inc. 8-K/A

pharmacyte_8ka.htm

8-K

8-K/A

pharmacyte_ex2301.htm

EX-23.1

CONSENT OF STEPHANO SLACK LLC, INDEPENDENT AUDITOR OF Q/C

pharmacyte_ex2302.htm

EX-23.2

CONSENT OF MORISON COGEN LLP, INDEPENDENT AUDITOR OF Q/C

pharmacyte_ex9901.htm

EX-99.1

Q/C AUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2024 AND 2023, AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023, TOGETHER WITH THE NOTES THERETO AND REPORTS OF INDEPENDENT AUDITORS THEREON.

pharmacyte_ex9902.htm

EX-99.2

Q/C UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2025, AND FOR THE SIX MONTHS ENDED JUNE 30, 2025, TOGETHER WITH THE NOTES THERETO.

pharmacyte_ex9903.htm

EX-99.3

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

pmcb-20250902.xsd

EX-101.SCH

XBRL SCHEMA FILE

pmcb-20250902_lab.xml

EX-101.LAB

XBRL LABEL FILE

pmcb-20250902_pre.xml

EX-101.PRE

XBRL PRESENTATION FILE

R1.htm

XML

IDEA: XBRL DOCUMENT

Show.js

XML

IDEA: XBRL DOCUMENT

report.css

XML

IDEA: XBRL DOCUMENT

FilingSummary.xml

XML

IDEA: XBRL DOCUMENT

MetaLinks.json

JSON

IDEA: XBRL DOCUMENT

0001683168-25-008512-xbrl.zip

ZIP

IDEA: XBRL DOCUMENT

pharmacyte_8ka_htm.xml

XML

IDEA: XBRL DOCUMENT